Loading organizations...
Key people at Fjor.
Fjör develops science-backed microbiome skincare products, featuring its proprietary Hydrolytic® Enzyme technology. Its core product line, including serums and moisturizers, targets sensitive and reactive skin. By clearing bacterial biofilms, Fjör restores natural barrier functions, fostering resilience, improving hydration, reducing redness, and balancing the microbiome.
The company originated from a collective of scientists and innovators, recognizing how modern environmental factors disrupt the skin's natural microbiome, causing widespread sensitivity. This insight was built upon three decades of Swedish research, culminating in the Hydrolytic® Enzyme, invented by Dr. Mats Clarsund PhD, to address the "skin microbiome crisis."
Fjör serves individuals with sensitive, dry, or overreactive skin, providing effective, science-driven solutions. Its vision is to empower customers with tools and knowledge to cultivate a diverse skin microbiome, simplifying routines for potent results. The company aims to restore skin health and confidence, leading to healthier, more radiant complexions.
Key people at Fjor.
Fjor has 1 tracked investment across 1 company. The latest tracked deal is $2.0M Seed in WorkDone in May 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2025 | WorkDone | $2.0M Seed | — | Pareto Holdings, TQ Ventures, TOM Blomfield, Eric Norman, Ryan Chan, DVC, Pioneer Fund |